199 related articles for article (PubMed ID: 32176769)
1. Somatic selection distinguishes oncogenes and tumor suppressor genes.
Chandrashekar P; Ahmadinejad N; Wang J; Sekulic A; Egan JB; Asmann YW; Kumar S; Maley C; Liu L
Bioinformatics; 2020 Mar; 36(6):1712-1717. PubMed ID: 32176769
[TBL] [Abstract][Full Text] [Related]
2. Statistically identifying tumor suppressors and oncogenes from pan-cancer genome-sequencing data.
Kumar RD; Searleman AC; Swamidass SJ; Griffith OL; Bose R
Bioinformatics; 2015 Nov; 31(22):3561-8. PubMed ID: 26209800
[TBL] [Abstract][Full Text] [Related]
3. DORGE: Discovery of Oncogenes and tumoR suppressor genes using Genetic and Epigenetic features.
Lyu J; Li JJ; Su J; Peng F; Chen YE; Ge X; Li W
Sci Adv; 2020 Nov; 6(46):. PubMed ID: 33177077
[TBL] [Abstract][Full Text] [Related]
4. Novel ratio-metric features enable the identification of new driver genes across cancer types.
Sudhakar M; Rengaswamy R; Raman K
Sci Rep; 2022 Jan; 12(1):5. PubMed ID: 34997044
[TBL] [Abstract][Full Text] [Related]
5. Oncogenes and tumor suppressor genes: comparative genomics and network perspectives.
Zhu K; Liu Q; Zhou Y; Tao C; Zhao Z; Sun J; Xu H
BMC Genomics; 2015; 16 Suppl 7(Suppl 7):S8. PubMed ID: 26099335
[TBL] [Abstract][Full Text] [Related]
6. Cumulative haploinsufficiency and triplosensitivity drive aneuploidy patterns and shape the cancer genome.
Davoli T; Xu AW; Mengwasser KE; Sack LM; Yoon JC; Park PJ; Elledge SJ
Cell; 2013 Nov; 155(4):948-62. PubMed ID: 24183448
[TBL] [Abstract][Full Text] [Related]
7. SomInaClust: detection of cancer genes based on somatic mutation patterns of inactivation and clustering.
Van den Eynden J; Fierro AC; Verbeke LP; Marchal K
BMC Bioinformatics; 2015 Apr; 16():125. PubMed ID: 25903787
[TBL] [Abstract][Full Text] [Related]
8. IDENTIFY CANCER DRIVER GENES THROUGH SHARED MENDELIAN DISEASE PATHOGENIC VARIANTS AND CANCER SOMATIC MUTATIONS.
Ma M; Wang C; Glicksberg BS; Schadt EE; Li SD; Chen R
Pac Symp Biocomput; 2017; 22():473-484. PubMed ID: 27896999
[TBL] [Abstract][Full Text] [Related]
9. The co-regulatory networks of tumor suppressor genes, oncogenes, and miRNAs in colorectal cancer.
Slattery ML; Herrick JS; Mullany LE; Samowitz WS; Sevens JR; Sakoda L; Wolff RK
Genes Chromosomes Cancer; 2017 Nov; 56(11):769-787. PubMed ID: 28675510
[TBL] [Abstract][Full Text] [Related]
10. Detection of oncogenic and clinically actionable mutations in cancer genomes critically depends on variant calling tools.
Garcia-Prieto CA; Martínez-Jiménez F; Valencia A; Porta-Pardo E
Bioinformatics; 2022 Jun; 38(12):3181-3191. PubMed ID: 35512388
[TBL] [Abstract][Full Text] [Related]
11. Use of signals of positive and negative selection to distinguish cancer genes and passenger genes.
Bányai L; Trexler M; Kerekes K; Csuka O; Patthy L
Elife; 2021 Jan; 10():. PubMed ID: 33427197
[TBL] [Abstract][Full Text] [Related]
12. A Mouse-Specific Model to Detect Genes under Selection in Tumors.
Chen H; Shu J; Maley CC; Liu L
Cancers (Basel); 2023 Oct; 15(21):. PubMed ID: 37958330
[TBL] [Abstract][Full Text] [Related]
13. OncodriveROLE classifies cancer driver genes in loss of function and activating mode of action.
Schroeder MP; Rubio-Perez C; Tamborero D; Gonzalez-Perez A; Lopez-Bigas N
Bioinformatics; 2014 Sep; 30(17):i549-55. PubMed ID: 25161246
[TBL] [Abstract][Full Text] [Related]
14. OncoVar: an integrated database and analysis platform for oncogenic driver variants in cancers.
Wang T; Ruan S; Zhao X; Shi X; Teng H; Zhong J; You M; Xia K; Sun Z; Mao F
Nucleic Acids Res; 2021 Jan; 49(D1):D1289-D1301. PubMed ID: 33179738
[TBL] [Abstract][Full Text] [Related]
15. Machine Learning Classification and Structure-Functional Analysis of Cancer Mutations Reveal Unique Dynamic and Network Signatures of Driver Sites in Oncogenes and Tumor Suppressor Genes.
Agajanian S; Odeyemi O; Bischoff N; Ratra S; Verkhivker GM
J Chem Inf Model; 2018 Oct; 58(10):2131-2150. PubMed ID: 30253099
[TBL] [Abstract][Full Text] [Related]
16. Distinct and competitive regulatory patterns of tumor suppressor genes and oncogenes in ovarian cancer.
Zhao M; Sun J; Zhao Z
PLoS One; 2012; 7(8):e44175. PubMed ID: 22952919
[TBL] [Abstract][Full Text] [Related]
17. Pitfalls in experimental designs for characterizing the transcriptional, methylational and copy number changes of oncogenes and tumor suppressor genes.
Zhang Y; Xia J; Zhang Y; Qin Y; Yang D; Qi L; Zhao W; Wang C; Guo Z
PLoS One; 2013; 8(3):e58163. PubMed ID: 23472150
[TBL] [Abstract][Full Text] [Related]
18. Multi-Omic Data Improve Prediction of Personalized Tumor Suppressors and Oncogenes.
Sudhakar M; Rengaswamy R; Raman K
Front Genet; 2022; 13():854190. PubMed ID: 35620468
[TBL] [Abstract][Full Text] [Related]
19. QuaDMutNetEx: a method for detecting cancer driver genes with low mutation frequency.
Bokhari Y; Alhareeri A; Arodz T
BMC Bioinformatics; 2020 Mar; 21(1):122. PubMed ID: 32293263
[TBL] [Abstract][Full Text] [Related]
20. SB Driver Analysis: a Sleeping Beauty cancer driver analysis framework for identifying and prioritizing experimentally actionable oncogenes and tumor suppressors.
Newberg JY; Black MA; Jenkins NA; Copeland NG; Mann KM; Mann MB
Nucleic Acids Res; 2018 Sep; 46(16):e94. PubMed ID: 29846651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
